52809-19-5Relevant articles and documents
Electroreductive 4-Pyridylation of Electron-deficient Alkenes with Assistance of Ni(acac)2
Findlater, Michael,Li, Guigen,Li, Lijun,Li, Xinru,Xu, Kun,Zhang, Junqi,Zhang, Sheng
, p. 3570 - 3575 (2020/04/21)
An electroreductive 4-pyridylation of activated alkenes was developed in an undivided cell with the assistance of Ni(acac)2 (acac = acetylacetone). This novel protocol is compatible with a broad range of electron-poor alkenes, which are commonl
Synthesis and utility of dihydropyridine boronic esters
Panda, Santanu,Coffin, Aaron,Nguyen, Q. Nhu,Tantillo, Dean J.,Ready, Joseph M.
supporting information, p. 2205 - 2209 (2016/02/18)
When activated by an acylating agent, pyridine boronic esters react with organometallic reagents to form a dihydropyridine boronic ester. This intermediate allows access to a number of valuable substituted pyridine, dihydropyridine, and piperidine products.
CHEMOKINE RECEPTOR BINDING COMPOUNDS
-
Page/Page column 103, (2008/06/13)
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. Thesd compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).